Dr. David Sugarbaker, Founder of the International Mesothelioma Program
Approximately 2,000 new patients are diagnosed with mesothelioma every year. With 310 consultations per year and more than 180 patients, the International Mesothelioma Program (IMP) at Brigham and Women's Hospital / Harvard Medical School is the largest program of its kind in the world.
Founded by David J. Sugarbaker, MD, the IMP encompasses a clinical program, a research program and a support program. Our clinical focus is on developing treatment strategies that can significantly extend the life of our patients. Our research focus involves a collaboration of basic, translational, and clinical research scientists whose aim is to understand the causative factors in the development of the disease and to translate these findings into improved therapy.
As seen on BostonMed 7.1.2010:
"When hope is in the equation, anything is possible"
That's what BWH Chief of Thoracic Surgery David Sugarbaker, MD, told the family of mesothelioma patient Charlie Chew, who was featured in last night's episode (7.1.2010) of "Boston Med."
Hear what Dr. Sugarbaker has to say about Mr. Chew and the team members who played a crucial role in saving his life.
As seen on ABC News 7.20.2010:
See Karen Grant's story as aired on the Boston WCVB Channel 5.
Send Feedback to:
Tamara Tilleman, MD/PhD
This page was last modified on 7/22/2010